MA-0217 (ASP1128)

ASP1128 · Astellas Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MA-0217 (ASP1128), covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects [Phase 1]